Holdings

华东医药股份有限公司

As of Aug 25, 2025, 华东医药股份有限公司 reported 2 positions. Largest: Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H and Qyuns Therapeutics Co., Ltd. Class H. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H12.6Mfirst reportNov 28, 2024
Qyuns Therapeutics Co., Ltd. Class H37.9Mfirst reportAug 25, 2025